Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Bram Baert
Advertisement
Bram Baert, Global Head of Regulatory Affairs at Capsugel
Articles by Bram Baert
Advertisement
Latest Updated Articles
Advertisement
Advertisement